Optometric Management Supplements

OphthalmicASC FEB 2016

Issue link: http://ophthalmologymanagementsupplements.epubxp.com/i/633882

Contents of this Issue

Navigation

Page 0 of 36

Headlights. Not halos. There's an unmistakable diference between what you can achieve with a standard multifocal and what your patients experience with Crystalens ® AO IOL. Crystalens delivers 100% of the light, 100% of the time, and minimizes issues with neuroadaptation, halos, and glare. 1,2 Crystalens Accommodating Posterior Chamber Intraocular Lens BRIEF STATEMENT Rx only. Indications for Use: The Crystalens is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia secondary to the removal of a cataractous lens in adult patients with and without presbyopia. The Crystalens provides approximately one diopter of monocular accommodation which allows for near, intermediate, and distance vision without spectacles. Warnings: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/beneft ratio before implanting a lens in a patient. Some adverse events which have been associated with the implantation of intraocular lenses are: hypopyon, intraocular infection, acute corneal decompensation, and secondary surgical intervention. Precautions: Do not resterilize; do not store over 45°C. ATTENTION: Refer to the Physician Labeling for complete prescribing information. References: 1. Ang R. Comparison of 3 presbyopia-correcting IOLs used in cataract surgery. Presented at: XXIX Congress of the European Society of Cataract & Refractive Surgeons (ESCRS); September 17-21, 2011; Vienna, Austria. 2. Pepose JS, Qazi MA, Davies J, et al. Visual performance of patients with bilateral vs combination Crystalens, ReZoom, and ReSTOR intraocular lens implants. Am J Ophthalmol . 2007;144(3):347-357. Crystalens is a trademark of Bausch & Lomb Incorporated or its afliates. All other product/brand names are trademarks of their respective owners. ©2015 Bausch & Lomb Incorporated. SUR/CRS/15/0021 OutcomesThatLast.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Optometric Management Supplements - OphthalmicASC FEB 2016